XM does not provide services to residents of the United States of America.

China and HK stocks rise, but stimulus, US election uncertainty temper gains



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>China and HK stocks rise, but stimulus, US election uncertainty temper gains</title></head><body>

Update prices; Adds details

SHANGHAI, Oct 25 (Reuters) -China stocks rose on Friday and were also up for the week, though investors were reluctant to place big bets as they await details of Beijing's fiscal stimulus and next month's U.S. election results.

Hong Kong stocks also gained, but were on track for a third consecutive weekly loss, as late September euphoria dissipates.

China's blue-chip CSI300 Index .CSI300 and the Shanghai Composite Index .SSEC both edged up roughly 1%, and were up 1.2% and 1.4% respectively, for the week.

Hong Kong's Hang Seng Index .HSI rose 1.1%, but is so far down 0.4% for the week.

China and Hong Kong stocks surged last month after Beijing kicked off its biggest stimulus since the pandemic, but the heavy outflows this month appear to have put the brakes on that sweeping rally for now.

Global hedge funds have clawed back nearly 80% of the peak cumulative buying in Chinese equities as of Oct.23, Goldman Sach's prime brokers team estimates.

China stock market turnover, which hit record levels on Oct 8, has been shrinking since, suggesting growing caution from investors looking for direction, Founder Securities investor advisor Luo Xuhong said in a note to clients.

"The market is getting uneasy about fiscal stimulus", the details of which have not yet been announced, Luo said.

The Nov 5 U.S. election is also keeping investors on edge.

A win for Republican Donald Trump, particularly if accompanied by a Republican sweep of Congress, is expected to squeeze the yuan and shares in the export sector.

A victory for Democrat Kamala Harris is likely to result in opposite trades.

"In Trump wins, the U.S. is expected to levy fresh tariff on Chinese goods," Haitong Securities said in a report.

China's small-caps outperformed blue-chips on Friday, with the CSI 2000 Index .CSI932000 jumping 2.3%, compared with a gain of 0.9% in the CSI Meg-cap Index .CSI000980.

Winners include photovolaic .CSI931151, media .CSI399810 and electronics stocks .CSI399811, while losers include utilities .CSI000917, banking .CSI399986 and telecom services shares .CSI932140.

In Hong Kong, most sectors rose, with industrials .HSCIIG, biotech .HSHKBIO and information technology shares .HSIT led the gains.


China stocks rally strongly https://reut.rs/3ZQNtV0

China's benchmark stock index logs biggest daily gain since 2008 https://reut.rs/4dmrDfq


Reporting by Shanghai Newsroom; Editing by Muralikumar Anantharaman and Shri Navaratnam

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.